Synthesis and synergistic antimycobacterial screening of chlorpromazine and its metabolites

about

Synthesis and synergistic antimycobacterial screening of chlorpromazine and its metabolites

Item

http://www.wikidata.org/entity/Q58866930

description

im Januar 2014 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Synthesis and synergistic anti ...... rpromazine and its metabolites

@en

Synthesis and synergistic anti ...... rpromazine and its metabolites

@nl

type

Item

label

Synthesis and synergistic anti ...... rpromazine and its metabolites

@en

Synthesis and synergistic anti ...... rpromazine and its metabolites

@nl

prefLabel

Synthesis and synergistic anti ...... rpromazine and its metabolites

@en

Synthesis and synergistic anti ...... rpromazine and its metabolites

@nl

P1476

Synthesis and synergistic anti ...... rpromazine and its metabolites

@en

P2093

Elizabeth M. Kigondu

http://www.w3.org/2001/XMLSchema#string

Kawaljit Singh

http://www.w3.org/2001/XMLSchema#string

Nicholas Njuguna

http://www.w3.org/2001/XMLSchema#string

P2860

Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300

Thioridazine: resurrection as an antimicrobial agent?

Chlorpromazine: a drug potentially useful for treating mycobacterial infections

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.

In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.

Parsimonious discovery of synergistic drug combinations.

Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy.

Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.

Pharmacokinetics of chlorpromazine after single and chronic dosage.

P304

502-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C3MD00387F

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kelly Chibale

Mathew Njoroge

Digby F Warner

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime